Search research articles
Contact Us
Filters
Showing results (101-110 of 177) with videos related to
Page
of 18
Sort By:
Nature Nanotechnology
|
August 17, 2023
Programmable multispecific DNA-origami-based T-cell engagers
Klaus F Wagenbauer, Nhi Pham, Adrian Gottschlich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells
Sebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Blood
|
October 3, 2018
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia
Monika Herrmann, Christina Krupka, Katrin Deiser, et al.
Haematologica
|
May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma
Djordje Atanackovic, Jens Panse, York Hildebrandt, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
Tim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2026
RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma
Anne Marie Senz, Bruno L Cadilha, Julia Teppert, et al.
Blood
|
June 3, 2020
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger, Tanja A Stief, Theresa Kaeuferle, et al.
Science Translational Medicine
|
September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models
Marcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 177) with videos related to
Sort By:
Page
of 18
Nature Nanotechnology
|
August 17, 2023
Programmable multispecific DNA-origami-based T-cell engagers
Klaus F Wagenbauer, Nhi Pham, Adrian Gottschlich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells
Sebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Blood
|
October 3, 2018
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia
Monika Herrmann, Christina Krupka, Katrin Deiser, et al.
Haematologica
|
May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma
Djordje Atanackovic, Jens Panse, York Hildebrandt, et al.
Journal for Immunotherapy of Cancer
|
July 28, 2022
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors
Sophia Stock, Mohamed-Reda Benmebarek, Anna-Kristina Kluever, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
Tim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2026
RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma
Anne Marie Senz, Bruno L Cadilha, Julia Teppert, et al.
Blood
|
June 3, 2020
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger, Tanja A Stief, Theresa Kaeuferle, et al.
Science Translational Medicine
|
September 15, 2021
Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models
Marcel André Schneider, Laura Heeb, Michal Mateusz Beffinger, et al.
Page
of 18